MK0869 (0869-073)

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0869 (0869-073), covering 2017-05-05 to 2017-05-05. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073) [Phase 3]